Portugal

Obesity. WHO advises against treatment in children under 10 years

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 07/10/2026, 12:31:24 UTC.

Briefings

The World Health Organization (WHO) issued a warning on October 7, 2026, advising against treating adolescents under 10 years old with approved medications. This recommendation applies specifically to cases where supervised follow-up programs failed to achieve expected outcomes, emphasizing the need for careful clinical assessment before initiating pharmacological intervention.

Key points

• The World Health Organization (WHO) issued a warning on October 7, 2026, advising against treating adolescents under 10 years old with approved medications.
• This recommendation applies specifically to cases where supervised follow-up programs failed to achieve expected outcomes, emphasizing the need for careful clinical assessment before initiating pharmacological intervention.

Context

The World Health Organization (WHO) issued a warning on October 7, 2026, advising against treating adolescents under 10 years old with approved medications. This recommendation applies specifically to cases where supervised follow-up programs failed to achieve expected outcomes, emphasizing the need for careful clinical assessment before initiating pharmacological intervention.

Limitations

The evidence is limited to a single sentence warning from the WHO regarding adolescent medication treatment. No specific case numbers, patient demographics, or detailed failure metrics are provided in the source text.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/10/2026, 04:02:27 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidepxttvhclksvxtowitqhzpwhhxtbdihb2qmvzfmyek4efnrjrde